SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 32 filers reported holding SCPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $71,445 | -20.6% | 14,232 | -0.9% | 0.00% | – |
| Q4 2023 | $90,006 | -12.3% | 14,355 | -0.4% | 0.00% | -100.0% |
| Q3 2023 | $102,613 | -27.6% | 14,412 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $141,641 | +424.6% | 13,900 | +240.8% | 0.00% | – |
| Q1 2021 | $27,000 | +22.7% | 4,079 | +0.3% | 0.00% | – |
| Q4 2020 | $22,000 | -29.0% | 4,068 | -2.8% | 0.00% | – |
| Q3 2020 | $31,000 | +29.2% | 4,186 | +27.4% | 0.00% | – |
| Q2 2020 | $24,000 | +84.6% | 3,287 | -24.2% | 0.00% | – |
| Q1 2019 | $13,000 | -23.5% | 4,338 | -3.1% | 0.00% | – |
| Q4 2018 | $17,000 | -34.6% | 4,478 | -0.8% | 0.00% | – |
| Q3 2018 | $26,000 | +4.0% | 4,513 | +1.9% | 0.00% | – |
| Q2 2018 | $25,000 | -56.9% | 4,431 | -5.9% | 0.00% | – |
| Q1 2018 | $58,000 | – | 4,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,051,805 | $20,907,893 | 8.53% |
| 5AM Venture Management, LLC | 1,200,647 | $12,234,593 | 3.05% |
| Worth Venture Partners, LLC | 512,337 | $5,220,714 | 2.84% |
| COWEN AND COMPANY, LLC | 1,837,918 | $18,728,384 | 1.55% |
| Orbimed Advisors | 5,559,528 | $56,651,590 | 1.03% |
| RTW INVESTMENTS, LP | 3,297,843 | $33,605,020 | 0.64% |
| EAM Investors, LLC | 265,528 | $2,705,730 | 0.50% |
| Rubric Capital Management LP | 811,517 | $8,269,358 | 0.35% |
| Ikarian Capital, LLC | 150,000 | $1,528,500 | 0.24% |
| Leucadia National | 831,000 | $8,467,890 | 0.08% |